600+ sources. One page. See who else covered it.
We haven't written up this one. Times of India has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Artificial intelligence is often framed as the technology that suddenly changed drug discovery. But that narrative misses an important truth: computational, or in silico, drug discovery did not begin with AI. It has been part of pharmaceutical research for decades.
The standard for AI agents is not how quickly they respond, but how many issues they resolve. That is why resolution has to be treated as an operating discipline.
Taksali points out that FPIs invested around ₹20,000 crore in Indian equities in July, followed by another ₹12,921 crore in the first week of August.
SEOUL, Aug. 13 (Yonhap) -- South Korea's Naver Corp. said Thursday it has made a...
Enthusiasm for tech hardware stocks is returning on evidence of continued massive AI spending by global big tech firms
AI-generated illustrations published in Australian newspapers have raised fears about the future of the cartooning industry, which one artist says is "shrinking dramatically".